Degarelix | CAS:214766-78-6

We serve Degarelix CAS:214766-78-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Degarelix

Chemical Name:Degarelix
CAS.NO:214766-78-6
Synonyms:Degarelix
Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Molecular Formula C82H103ClN18O16
Molecular Weight 1632.259
Index of Refraction 1.620
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Degarelix (INN) or degarelix acetate (USAN) (trade name Firmagon) has an immediate onset of action, binding to gonadotropin-releasing hormone (GnRH) receptors in the pituitary gland and blocking their interaction with GnRH. This induces a fast and profound reduction in luteinising hormone (LH), follicle-stimulating hormone (FSH) and in turn, testosterone suppression. Testosterone is a male hormone that promotes growth of many prostate tumours.



Contact us for information like Degarelix chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Degarelix Use and application,Ac-D-Nal-[D-(pCl)Phe]-D-Pal-Ser-[Aph(DHor)]-D-[Aph(Cbm)]-Leu-ILys-Pro-DAla-NH2 technical grade,usp/ep/jp grade.


Related News: The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.4-tert-Butylphenylboronic acid manufacturer The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.N-Methyl-1,2-benzenediamine dihydrochloride supplier Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.4-Propyl-3'-Fluorobiphenyl-4'-Boronic Acid vendor Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.In these situations, the API is not a single substance but the culmination of various ingredients.